ARCALYST Trademark

Trademark Overview

On Sunday, March 29, 2020, a trademark application was filed for ARCALYST with the United States Patent and Trademark Office. The USPTO has given the ARCALYST trademark a serial number of 88851874. The federal status of this trademark filing is REGISTERED as of Tuesday, November 1, 2022. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The ARCALYST trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceutical preparations and substances for the treatment of inflammatory diseases and disorders
arcalyst

General Information

Serial Number88851874
Word MarkARCALYST
Filing DateSunday, March 29, 2020
Status700 - REGISTERED
Status DateTuesday, November 1, 2022
Registration Number6890079
Registration DateTuesday, November 1, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements

Description of MarkThe mark consists of the word "Arcalyst" in a stylized font with a diamond shape above the letter "y".
Goods and ServicesInjectable pharmaceutical preparations and substances for the treatment of inflammatory diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 3, 2020
Primary Code005
First Use Anywhere DateThursday, April 1, 2021
First Use In Commerce DateThursday, April 1, 2021

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Tuesday, November 1, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 1, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, September 29, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 28, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 7, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 23, 2022USE AMENDMENT FILED
Wednesday, September 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 23, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, February 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 23, 2022SOU EXTENSION 3 GRANTED
Wednesday, February 23, 2022SOU EXTENSION 3 FILED
Wednesday, February 23, 2022TEAS EXTENSION RECEIVED
Friday, August 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 11, 2021SOU EXTENSION 2 GRANTED
Wednesday, August 11, 2021SOU EXTENSION 2 FILED
Wednesday, August 11, 2021TEAS EXTENSION RECEIVED
Friday, February 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 24, 2021SOU EXTENSION 1 GRANTED
Wednesday, February 24, 2021SOU EXTENSION 1 FILED
Wednesday, February 24, 2021TEAS EXTENSION RECEIVED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 15, 2020ASSIGNED TO LIE
Thursday, June 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 9, 2020ASSIGNED TO EXAMINER
Saturday, April 4, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, April 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, April 1, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

arcalyst inflammatory diseases disorders treatment substances pharmaceutical preparations injectable